Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 588.00
Bid: 580.00
Ask: 596.00
Change: -2.00 (-0.34%)
Spread: 16.00 (2.759%)
Open: 590.00
High: 596.00
Low: 588.00
Prev. Close: 590.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commencement of Trading on OTCQX in the U.S.

22 May 2024 07:00

RNS Number : 3501P
Warpaint London PLC
22 May 2024
 

Warpaint London PLC

("Warpaint" or the "Company")

 

Commencement of Trading on OTCQX in the U.S.

 

London, May 22, 2024 - Warpaint London plc (AIM: W7L, OTCQX: WPNTF), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, is pleased to announce that its ordinary shares have been approved to trade on the OTCQX® Best Market ("OTCQX") in the United States of America ("United States" or "U.S.") and will commence trading at the market open today under the ticker symbol 'WPNTF'. Warpaint's ordinary shares will continue to trade on the AIM market of the London Stock Exchange.

 

The Company believes that having its ordinary shares cross-traded on OTCQX will provide enhanced investor benefits, including easier trading access for certain investors located in the United States, and greater liquidity due to a broader geographic pool of potential investors. Through trading on OTCQX, the Company will be able to engage with U.S. investors, data distributors and media partners, ensuring that they have access to the same level of information and disclosure available to investors in the United Kingdom, but through U.S.-facing platforms and portals. In addition, the OTCQX trading facility will provide U.S.-based and other investors with the ability to trade Warpaint's ordinary shares in U.S. dollars during U.S. market hours.

 

No new ordinary shares will be issued as part of the commencement of trading on OTCQX. Warpaint will continue to make announcements and disclosures to the London Stock Exchange, and will have no Sarbanes-Oxley or SEC public company reporting requirements under the Securities Exchange Act of 1934 in connection with trading on OTCQX.

 

To qualify for OTCQX, Warpaint has demonstrated that it meets high financial standards and that it complies with applicable securities laws. Carter Ledyard & Milburn LLP, acted as the Company's OTCQX sponsor.

 

Commenting, Sam Bazini Chief Executive Officer of Warpaint, said:

 

"We believe that having Warpaint's shares trade on both the AIM and OTCQX markets will serve to increase exposure to a broader range of investors. This new U.S. trading facility comes on the back of an already increased level of interest from U.S. investors given the progress the Company is making with significant retailers in the U.S."

 

 

Enquiries:

Warpaint London plc

c/o IFC

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

Shore Capital (Nominated Adviser & Broker)

+44 (0)20 7408 4090

Patrick Castle, Daniel Bush - (Corporate Advisory)

Fiona Conroy - Corporate Broking

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

+44 (0)20 3934 6630

 

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brands of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint also sells cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFIRESILFIS
Date   Source Headline
12th Jun 20243:47 pmRNSHolding(s) in Company
7th Jun 20247:00 amRNSWarpaint to present Investor Conference
31st May 20247:00 amRNSDirector/PDMR Purchase of Shares
30th May 20242:31 pmRNSPDMR Dealings and Total Voting Rights
23rd May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd May 20247:00 amRNSCommencement of Trading on OTCQX in the U.S.
9th May 20243:48 pmRNSBlock listing Interim Return
7th May 20245:41 pmRNSHolding(s) in Company
3rd May 202412:50 pmRNSDirector / PDMR Dealings
3rd May 20247:00 amRNSResult of Accelerated Bookbuild in Warpaint
2nd May 20244:45 pmRNSProposed Accelerated Bookbuild in Warpaint
29th Apr 20247:37 amRNSHolding(s) in Company
24th Apr 20247:00 amRNSResults for the year ended 31 December 2023
9th Apr 20247:00 amRNSBlock listing Interim Return
9th Apr 20247:00 amRNSTrading Update and Notice of Results
26th Mar 20242:37 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSWard & Hagon Contract Renewal
12th Jan 20247:00 amRNSTrading Update
12th Dec 20237:00 amRNSAppointment of Non-Executive Directors
1st Dec 20233:37 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of Options
21st Nov 202311:23 amRNSPDMR Dealing
20th Nov 20231:24 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSBlock Listing Interim Return
31st Oct 20237:00 amRNSTotal Voting Rights
13th Oct 20233:38 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20233:26 pmRNSHolding(s) in Company
3rd Oct 202312:25 pmRNSBlocklisting Application
28th Sep 20235:47 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
19th Sep 20233:51 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
22nd Aug 202312:31 pmRNSHolding(s) in Company
27th Jul 20234:34 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20231:40 pmRNSResult of AGM
28th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSTrading Update
6th Jun 20237:00 amRNSPDMR Dealings
24th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
9th May 202311:28 amRNSHolding(s) in Company
2nd May 20234:31 pmRNSBlocklisting Application
26th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.